BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14294237)

  • 21. The heterogeneity of caeruloplasmin nd the enzymatic defect in Wilson's disease.
    RICHTERICH R; GAUTIER E; STILLHART H; ROSSI E
    Helv Paediatr Acta; 1960 Nov; 15():424-36. PubMed ID: 13741432
    [No Abstract]   [Full Text] [Related]  

  • 22. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease.
    Iyengar V; Brewer GJ; Dick RD; Chung OY
    J Lab Clin Med; 1988 Mar; 111(3):267-74. PubMed ID: 3125292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [WILSON'S DISEASE. HISTORICAL PROGRESS IN ITS STUDY, AND FUTURE RESEARCH WITH SPECIAL REFERENCE TO ABNORMALITIES OF COPPER METABOLISM].
    OGIHARA K
    Sogo Igaku; 1963 Sep; 20():649-54. PubMed ID: 14057196
    [No Abstract]   [Full Text] [Related]  

  • 25. Caeruloplasmin in Wilson's disease.
    ROSENOER VM; FRANGLEN G
    Lancet; 1959 Dec; 2(7113):1163-4. PubMed ID: 14439030
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of the need of ceruloplasmin and serum copper analyses in the diagnosis of Wilson's disease].
    Nomoto S; Kanai M; Matsuda Y
    Rinsho Byori; 1974 Oct; 22(10 Suppl):190. PubMed ID: 4475792
    [No Abstract]   [Full Text] [Related]  

  • 27. Ceruloplasmin in Wilson's disease.
    Holtzman NA; Naughton MA; Iber FL; Gaumnitz BM
    J Clin Invest; 1967 Jun; 46(6):993-1002. PubMed ID: 6026104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CLINICAL AND PATHOLOGICAL CHARACTERISTICS IN WILSON'S DISEASE IN CASES UNDER TEN YEARS OF AGE.
    ARIMA M; KOMIYA K; KAMOSHITA S; MUKAI N
    Paediatr Univ Tokyo; 1963 Dec; 9():17-22. PubMed ID: 14157269
    [No Abstract]   [Full Text] [Related]  

  • 29. Liver transplantation for Wilson's disease.
    Sevmis S; Karakayali H; Aliosmanoglu I; Yilmaz U; Ozcay F; Torgay A; Arslan G; Haberal M
    Transplant Proc; 2008; 40(1):228-30. PubMed ID: 18261593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
    Wald I; Galewicz A; Górska D
    Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular studies of ceruloplasmin deficiency in Wilson's disease.
    Czaja MJ; Weiner FR; Schwarzenberg SJ; Sternlieb I; Scheinberg IH; Van Thiel DH; LaRusso NF; Giambrone MA; Kirschner R; Koschinsky ML
    J Clin Invest; 1987 Oct; 80(4):1200-4. PubMed ID: 3654978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease.
    Li Y; Togashi Y; Sato S; Emoto T; Kang JH; Takeichi N; Kobayashi H; Kojima Y; Une Y; Uchino J
    J Clin Invest; 1991 May; 87(5):1858-61. PubMed ID: 2022751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Wilson's disease--a factor in the differential diagnosis in hepatopathies].
    Dastych M; Jezek P; Snelerová M
    Vnitr Lek; 1989 Jul; 35(7):695-700. PubMed ID: 2800377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CURRENT ASPECTS OF WILSON'S DISEASE].
    PETIT H
    Lille Med; 1964 Oct; 9():750-8. PubMed ID: 14210920
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of apo- and holo-forms of ceruloplasmin in patients with Wilson's disease using native polyacrylamide gel electrophoresis.
    Hirano K; Ogihara T; Ogihara H; Hiroi M; Hasegawa M; Tamai H
    Clin Biochem; 2005 Jan; 38(1):9-12. PubMed ID: 15607310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Families with Wilson's disease in subsequent generations: clinical and genetic analysis.
    Dzieżyc K; Litwin T; Chabik G; Gramza K; Członkowska A
    Mov Disord; 2014 Dec; 29(14):1828-32. PubMed ID: 25327413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 39. [Early diagnosis of Wilson's disease in childhood (author's transl)].
    Feist D; Wesch H; Schmid-Rüter E
    Monatsschr Kinderheilkd (1902); 1978 Jun; 126(6):371-4. PubMed ID: 661832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kayser-Fleischer ring in Wilson's disease].
    Hajare Q; Mehdi K
    Pan Afr Med J; 2018; 30():137. PubMed ID: 30374383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.